Urological Cancer Service | St. James's Hospital Foundation Urological Cancer Service | St. James's Hospital Foundation

Urological Cancer Service

St. James’s Hospital is a teaching hospital of Trinity College, Dublin and is the largest single provider of cancer treatment in Ireland. It is the largest national centre for radiation services. It consistently leads the way in new developments and treatments for cancer patients as well as providing excellence in the management of their care.


The Department of Urology at St. James’s Hospital treats patients with problems affecting the bladder, kidneys, prostate and genitalia – Problems in these areas include both non-cancerous and cancerous conditions.


Rapid Access Clinics


We have developed a number of “rapid access” clinics which allow a definitive diagnosis of cancer to be established quickly.


Patients are referred by their general practitioner to the rapid access prostate cancer clinics and offered an appointment to be seen at our clinic generally within two weeks. They will be assessed by a urologist and needle biopsies of the prostate will be performed as appropriate at the first visit.


As well as speeding up the assessment and allowing for an earlier definite diagnosis, the rapid access clinics also speeds up decision making for patients who are diagnosed with cancer. These clinics would not have been established except for the generous donations received.


We hope to establish rapid access clinics for other worrying symptoms but development of additional services is often hindered by lack of funding.


Urological Cancer Service

Lynn Casey and Marion O’Brien, Clinical Nurse Specialists in Urology

Urological Cancer Service team

Diarmuid Moran, Shaquille Inder and Louise Mc Loughlin, Specialist Registrars

Patient Education and Cancer Awareness

Another important aspect of our care is in patient education and in promoting awareness about cancers in the community. With better information people will be more aware of warning signs and less afraid to get medical help. Early detection of cancer improves the success of treatment.


Prevention and early detection of signs and symptoms is essential. We need to promote a greater awareness about men’s cancers throughout our community.

We hope you will help us to raise much needed funds, encouraging men and women to be less fearful and less reluctant to visit their doctor if they experience new symptoms.

Research at St James’s Hospital and Trinity College Dublin

Research is vital to the development of new cancer treatments. The Department of Urology here at St. James’s provides a clinical link to prostate cancer research in the laboratory. Our state-of-the-art research facility is affiliated with Trinity College Dublin and is situated on the St. James’s Hospital Campus itself. Our research is focused on finding better ways to diagnose and develop effective personalised treatments best for the individual patient.


iPROSPECT is the Irish PROgramme for Stratified ProstatE Cancer Therapy, set up in last year with funding from the Irish Cancer Society in partnership with Movember.


The iPROSPECT team is led by Prof Stephen Finn (St James’s Hospital and TCD), Dr RayMcDermott (TCD), and Prof William Watson(UCD). iPROSPECT has a set of projects, which aim to bring a transformation from current practice to a more individual and personalised treatment of our patients with metastatic prostate cancer so we can improve patient outcomes.

Supporting Our Service

Although the hospital is publicly funded, charitable donations from the public and business allow us to improve the service for our patients. We can do this by purchasing new equipment and improving the facilities for our patients. Funds will also be used in our research facility here at the hospital. Donations are very important in helping us develop our patient health education programmes.

Donations do not have to be large. Every little helps in making a difference to what we can do together for our patients and community.


Donations may be by companies, private individuals, or groups coming together to fundraise by holding events, or being sponsored.
St James’s Hospital Foundation is the registered charity supporting our hospital, and their team is ready to share with you and assist you in any community fundraising that you might want to do.


To find out more call 01 – 428 4086 or donate online here and select the Prostate Cancer option. All donations will be acknowledged on receipt of your gift.


Thank you for taking the time to read this page

Professor Thomas H Lynch MB, MMs, MCh, FRCS, FRCSI, FRCS(UROL)

Thomas H Lynch

Professor Thomas H Lynch is a consultant urological surgeon in St. James’s Hospital and Trinity College, Dublin. In addition to his special interest in Urological Oncology he is the lead urologist in laboratory based prostate cancer research with multiple publications in this area. He is a graduate of the National University of Ireland at Galway. He has an extensive training in urological oncology in the United States, the United Kingdom and Ireland.


Professor Lynch has a track record as an innovator, academic and teacher. He has lectured and published extensively on prostate cancer and has always been involved in new innovations in patient care.


He has a particular interest in laparoscopic surgery and also performs robotic surgery for men with localised early stage prostate cancer. He has been heavily involved in the development of national guidelines for prostate cancer diagnosis and chaired the expert group for the HSE. He was also a member of the expert group for the much acclaimed Irish Health Technology Assessment for HIQA on robotic surgery.


He is a member of the lead clinicians group advising the National Cancer Control Programme on further improvements in the diagnosis and treatment of men with prostate and other urological cancers. He maintains his up to date knowledge and expertise by attending international scientific meetings and lecturing around the world. He has extensive experience as organiser and faculty member of several clinical and research meetings at national and international conferences.


He has won several grant bids for research and clinical funding. He has also won several awards including The British Journal of Urology International award, The British Association of Urological Surgeons (BAUS) Prize and The International Association of Radiation Research Prize. He is an examiner for the Royal College of Surgeons in Ireland and Trinity College, Dublin and is a reviewer for several peer review journals.